Ocuphire Pharma, Inc.·4

Jun 13, 5:30 PM ET

Pepose Jay 4

4 · Ocuphire Pharma, Inc. · Filed Jun 13, 2024

Insider Transaction Report

Form 4
Period: 2024-06-11
Pepose Jay
Director
Transactions
  • Award

    Common Stock

    2024-06-11+41,143180,458 total
  • Award

    Stock Option (Right to Buy)

    2024-06-11+35,18135,181 total
    Exercise: $1.72Exp: 2034-06-10Common Stock (35,181 underlying)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
  • [F2]The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary